Ann Rheum Dis. Published Online First: 7 May 2007. doi:10.1136/ard.2006.065946
Extended Report |
Synthesis and release of human cartilage matrix proteoglycans are differently regulated by nitric oxide and prostaglandin-E2
1 UMC Utrecht, Netherlands
* To whom correspondence should be addressed. E-mail: s.mastbergen{at}umcutrecht.nl.
Accepted 30 April 2007
Abstract
Objectives: Recent studies showed beneficial effects of COX-2 inhibition on proteoglycan turnover of both IL-
/TNF
damaged cartilage and of osteoarthritic cartilage. Although proteoglycan release and content normalized, proteoglycan synthesis was only partially influenced. Prostaglandin-E2 is the main product formed by COX-2. We therefore evaluate the role of prostaglandin-E2 in relation to nitric oxide in disturbing cartilage proteoglycan turnover.
Methods: Human healthy cartilage, alone or in the presence of IL-
;+TNF
, was cultured for 7 days with or without prostaglandin-E2 or the selective COX-2 inhibitor (celecoxib 10µM). Changes in cartilage matrix proteoglycan turnover, levels of prostaglandin-E2 and nitric oxide were determined.
Results: Proteoglycan synthesis and release of the cartilage were not affected by prostaglandin-E2 alone. Addition of IL-
+TNF
to healthy cartilage resulted in inhibition of proteoglycan synthesis and increase in proteoglycan release. When prostaglandin-E2 was added, in addition to IL-
+TNF
, proteoglycan release further increased, but proteoglycan synthesis was not further influenced. Addition of a selective COX-2 inhibitor to the IL-
+TNF
treated cartilage inhibited the enhanced prostaglandin-E2 production and almost complete normalized proteoglycan release, whereas synthesis remained unaffected. Also the enhanced NO-levels remained elevated. Prostaglandin-E2 levels correlated significantly with proteoglycan release whereas NO levels correlated significantly with proteoglycan synthesis.
Conclusion: The present results suggest involvement of prostaglandin-E2 in enhanced cartilage proteoglycan release but not synthesis, although healthy cartilage has to be sensitized by IL-
+TNF
. IL-1£]+TNF
induced NO seems to be involved in inhibition of proteoglycan synthesis, independent of prostaglandin-E2 and thus seems insensitive to regulation by (selective) COX-2 inhibitors.
Keywords: COX-2, human cartilage tissue, prostaglandin-E2, proteoglycan turnover
This article has been cited by other articles:
-
Molloy, E S, Morgan, M P, Doherty, G A, McDonnell, B, O'Byrne, J, Fitzgerald, D J, McCarthy, G M
(2008). Mechanism of basic calcium phosphate crystal-stimulated matrix metalloproteinase-13 expression by osteoarthritic synovial fibroblasts: inhibition by prostaglandin E2. Ann Rheum Dis
67: 1773-1779
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
